[GALANTHAMINUM HYDROBROMICUM ("NIVALINE"), A NEW ANTIDOTE OF NON-POLARIZING MUSCLE RELAXANTS. PHARMACOLOGY AND CLINICAL USE].
D000758:Anesthesia; D000776:Anesthesiology; D000818:Animals; D000931:Antidotes; D001285:Atropine; D035843:Biomedical Research; D001919:Bradycardia; D002415:Cats; D005702:Galantamine; D051379:Mice; D009125:Muscle Relaxants, Central; D009388:Neostigmine; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D010600:Pharmacology; D011817:Rabbits; D051381:Rats
D000931:Antidotes; D009125:Muscle Relaxants, Central; D003473:Neuromuscular Nondepolarizing Agents; D005702:Galantamine; D009388:Neostigmine; D001285:Atropine
ANESTHESIA; ANTIDOTES; ATROPINE; BRADYCARDIA; CATS; CLINICAL RESEARCH; CURARIFORM ANTAGONISTS; GALANTHAMINE; MICE; MUSCLE RELAXANTS; NEOSTIGMINE; PHARMACOLOGY; RABBITS; RATS
GALANTHAMINUM HYDROBROMICUM "NIVALIN", EIN NEUES ANTIDOT DER NICHTDEPOLARISIERENDEN MUSKELRELAXANTIEN. PHARMAKOLOGIE UND KLINISCHE ANWENDUNG.